Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- Zeria Working to Strengthen Product Line-up in GI Field
September 6, 2004
- Profits Up for Top 10 Houses Despite 1.2% Decline in Sales
September 6, 2004
- Hokuyaku to Remain Regional Wholesalers Supporting Regional Med Institutions
September 6, 2004
- 1st Qtr Business Results
September 6, 2004
- Unfair Contracts Still Noted between Wholesalers and Med Institutions: Survey
September 6, 2004
- 1st Qtr Business Results －2－
August 30, 2004
- MONITOR
August 30, 2004
- Annual Business Results
August 30, 2004
- MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
August 30, 2004
- Sankyo to Strengthen Marketing of Ca Blocker Calblock
August 30, 2004
- Semi-annual Business Results
August 30, 2004
- OTC NEWS IN BRIEF
August 30, 2004
- DIAGNOSTIC NEWS IN BRIEF
August 30, 2004
- Approval of 4 NCEs Including Hepsera Recommended
August 30, 2004
- Kyorin to Continue License Accord with Merck & Co. on Joint Research in Antibacterials
August 30, 2004
- Wholesale Industry Should Standardize Ordering Systems: Kuraya Sanseido
August 30, 2004
- Korosho to Beef Up Drug Safety Measures: Dr Kurokawa
August 30, 2004
- Moroo Aims at 30% Market Share in Hokkaido
August 30, 2004
- REGULATORY NEWS IN BRIEF
August 30, 2004
- Towa to Use Pharmaceutical Technologies to Win Competition
August 30, 2004
ページ
Japan is ramping up its push to spread regional formularies nationwide, a policy expected to standardize treatments, strengthen supply resilience,…
We had just gotten off a call with a client in Europe, and we’d received a bit of an earful. “Philip,” the client pressed, “what can this candidate bring to us? We know what he does, but what has he…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…